Search results for " emerging markets"
Article
CDMOs Driving Emerging Bio/Pharma Success
CDMOs Driving Emerging Bio/Pharma Success
CDMOs can claim credit for the robust growth of emerging bio/pharma financings.
By Jim Miller
Emerging bio/pharmaceutical companie…
Article
Navigating Emerging Markets: Middle East and North Africa
Overall, according to the Central Intelligence Agency’s (CIA) World Factbook, the population is growing in every Middle Eastern and North African country, and is generally younger than the emerging ma…
Article
Brazil Emerges as Global Biopharm Collaborator
Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator.
The pharmaceutical market in Brazil has been growing steadily and strongly in the past five ye…
Article
Tools and Processes for Mature and Emerging Therapies
New technologies and thought trends provide innovative biomanufacturing approaches for a range of therapies.
By Rita Peters
Conference sessions and new technology introductions at recent t…
Article
Emerging biopharma: progressing a biologic drug to market
There are many pitfalls in the road to developing and bringing a new therapy to market. Understanding some of these areas and being prepared to make the right decisions at the right ti…
Article
Emerging Therapies Test Existing Bioanalytical Methods
Drug developers must understand the complex bioanalytical assays for cell- and gene-therapy drug development programs and ensure that partners have the specialized expertise needed for complex thera…
Article
The Bullish Outlook for Biosimilars
Other markets, including emerging markets, such as Latin America and South Korea, have relied on both the European Medicines Agency (EMA) and the World Health Organization (WHO) for guideline developm…
Article
Monoclonal Antibodies Key to Unlocking the Biosimilars Market
Development of clear, regulatory approval pathways for biosimilars in emerging markets is creating large, additional opportunities for biosimilar mAbs. Education of physicians, pharmacists, and patien…
Article
Drugs, At What Cost?
In emerging markets (more than 20 nations including China, Brazil, India, Russia, Mexico, and Turkey), growth will increase from $26 billion in 2012 to $30-50 billion in 2017, primarily due to increas…
Article
Biomanufacturing Outsourcing Globalization Continues
Nevertheless, the future looks brighter for CMOs in emerging markets, as they continue to develop regional manufacturing clusters. China (8.6%) and India (8.1%) together account for approximately one-…